Bibliografia UJ CM

1/3
A.T. Oosterom, H.T. Mouridsen, O.S. Nielsen, P. Dombernowsky, K[rzysztof] Krzemieniecki, I. Judson, L. Svancarova, D. Spooner, C. Hermans, M. van Glabbeke, J. Verweij, EORTIC STBSG.
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
European Journal of Cancer
2002 : Vol. 38, nr 18, s. 2397-2406, il., bibliogr. 30 poz., abstr.
AZ
ORG
AIF
IF: 3.562
2/3
O.S. Nielsen, I. Judson, Q. van Hoesel, A. le Cesne, H.J. Keizer, J.Y. Blay, A. van Oosterom, J.A. Radford, L. Svancarova, K[rzysztof] Krzemieniecki, C. Hermans, M. van Glabbeke, J.W. Oosterhuis, J. Verweij.
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
European Journal of Cancer
2000 : Vol. 36, nr 1, s. 61-67, il., bibliogr. 28 poz., abstr.
AZ
ORG
AIF
IF: 2.725
3/3
J. Verweij, K[rzysztof] Krzemieniecki, T. Kok, A. Poveda, C. Vanpottelseberghe, M. Vanglabbeke, H. Mouridsen.
Phase-ii study of miltefosine (hexadecylphosphocholine) in advanced soft-tissue sarcomas of the adult - an eortc-soft-tissue-and-bone-sarcoma-group study.
European Journal of Cancer
1993 : Vol. 29A, nr 2, s. 208-209, il. bibliogr., abstr.
AZ
ORG
AIF
IF: 1.959
Wyświetl ponownie stosując format: